We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Xperi (XPER) to Report Q4 Earnings: What's in the Cards?
Read MoreHide Full Article
Xperi Corporation (XPER - Free Report) is set to release fourth-quarter 2018 results on Feb 20, after the bell. In the last reported quarter, the company delivered positive earnings surprise of 16.7%.
Shares of the company have rallied 38.9% in the past six months, against 12.4% decline of the industry.
Let’s see how things are shaping up for this announcement.
Factors at Play
Xperi’s product licensing business is expected to stay robust as the fourth quarter is a seasonally strong period. Partnerships with IMAX and Cineplex are enabling the company with market expansion and penetration.Xperi’s automotive business is likely to be in good shape on the back of strong DMS and HD radio businesses.
The company’s home market is expected to benefit from increased AVR sound bar and TV customer penetration driven by the greater adoption of the virtual X and DTSX solutions.
The IP licensing and semiconductor packaging business is expected to benefit from growing interest in the company’s hybrid bonding solutions. It has engaged multiple partners in evaluations of the DBI technology for memory applications including 3D NAND and DRAM.
Zacks Model Suggests a Beat
Please note that according to the Zacks model, a company with a Zacks Rank #1 (Strong Buy), 2 (Buy) or #3 (Hold) has a good chance of beating estimates if it also has a positive Earnings ESP. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Xperi has a Zacks Rank #3 and an Earnings ESP of 0.00%, a combination that makes surprise prediction difficult.
Stocks with a Zacks Rank #4 (Sell) or #5 (Strong Sell) are best avoided, especially if they have a negative Earnings ESP.
Stocks to Consider
Here are a few stocks from the broader Zacks Business Services sector that investors may consider as our model shows that these have the right combination of elements to beat estimates.
EVO Payments, Inc has an Earnings ESP of +1.89% and a Zacks Rank #3.
Conduent Incorporated (CNDT - Free Report) has Earnings ESP of +0.95% and a Zacks Rank #3.
Zacks' Top 10 Stocks for 2019
In addition to the stocks discussed above, wouldn't you like to know about our 10 finest buy-and-holds for the year?
From more than 4,000 companies covered by the Zacks Rank, these 10 were picked by a process that consistently beats the market. Even during 2018 while the market dropped -5.2%, our Top 10s were up well into double-digits. And during bullish 2012 – 2017, they soared far above the market's +126.3%, reaching +181.9%.
This year, the portfolio features a player that thrives on volatility, an AI comer, and a dynamic tech company that helps doctors deliver better patient outcomes at lower costs.
Image: Bigstock
Xperi (XPER) to Report Q4 Earnings: What's in the Cards?
Xperi Corporation (XPER - Free Report) is set to release fourth-quarter 2018 results on Feb 20, after the bell. In the last reported quarter, the company delivered positive earnings surprise of 16.7%.
Shares of the company have rallied 38.9% in the past six months, against 12.4% decline of the industry.
Let’s see how things are shaping up for this announcement.
Factors at Play
Xperi’s product licensing business is expected to stay robust as the fourth quarter is a seasonally strong period. Partnerships with IMAX and Cineplex are enabling the company with market expansion and penetration.Xperi’s automotive business is likely to be in good shape on the back of strong DMS and HD radio businesses.
The company’s home market is expected to benefit from increased AVR sound bar and TV customer penetration driven by the greater adoption of the virtual X and DTSX solutions.
The IP licensing and semiconductor packaging business is expected to benefit from growing interest in the company’s hybrid bonding solutions. It has engaged multiple partners in evaluations of the DBI technology for memory applications including 3D NAND and DRAM.
Zacks Model Suggests a Beat
Please note that according to the Zacks model, a company with a Zacks Rank #1 (Strong Buy), 2 (Buy) or #3 (Hold) has a good chance of beating estimates if it also has a positive Earnings ESP. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Xperi has a Zacks Rank #3 and an Earnings ESP of 0.00%, a combination that makes surprise prediction difficult.
Stocks with a Zacks Rank #4 (Sell) or #5 (Strong Sell) are best avoided, especially if they have a negative Earnings ESP.
Stocks to Consider
Here are a few stocks from the broader Zacks Business Services sector that investors may consider as our model shows that these have the right combination of elements to beat estimates.
Copart (CPRT - Free Report) has Earnings ESP of +1.63% and a Zacks Rank #2. You can see the complete list of today’s Zacks #1 Rank stocks here.
EVO Payments, Inc has an Earnings ESP of +1.89% and a Zacks Rank #3.
Conduent Incorporated (CNDT - Free Report) has Earnings ESP of +0.95% and a Zacks Rank #3.
Zacks' Top 10 Stocks for 2019
In addition to the stocks discussed above, wouldn't you like to know about our 10 finest buy-and-holds for the year?
From more than 4,000 companies covered by the Zacks Rank, these 10 were picked by a process that consistently beats the market. Even during 2018 while the market dropped -5.2%, our Top 10s were up well into double-digits. And during bullish 2012 – 2017, they soared far above the market's +126.3%, reaching +181.9%.
This year, the portfolio features a player that thrives on volatility, an AI comer, and a dynamic tech company that helps doctors deliver better patient outcomes at lower costs.
See Stocks Today >>